Posted by Gareth Icke - memes and headline comments by David Icke Posted on 19 February 2021

WHO Approves AstraZeneca Vaccine for Emergency Use (of course it does), But Some Nations Say ‘No Thanks’

The World Health Organization (WHO) Monday approved two versions of the AstraZeneca-Oxford COVID vaccine for emergency use despite growing safety concerns in other countries and earlier questions about the drugmaker’s clinical trials.

Countries like the U.S., UK, Israel, Saudi Arabia and others have their own regulatory process for granting emergency use approval for vaccines and other drugs, but those countries that lack the necessary regulatory framework rely on WHO to vet vaccines.

WHO’s approval of the vaccines produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India paves the way for 300 million doses of AstraZeneca to reach 145 countries in the first half of 2021, through Bill Gates’ COVAX program.

But while WHO is moving forward, other countries are hitting pause on AstraZeneca amid ongoing reports of side effects and lack of efficacy.

According to Fierce Pharma, the U.S. Food and Drug Administration (FDA) may not approve the AstraZeneca COVID vaccine due to inconsistent manufacturing concerns and a study released earlier this month showing the vaccine’s efficacy against mild and moderate COVID-19 cases was only 21.9%, well below the 50% threshold required for vaccine approval.

According to the Wall Street Journal, South Africa suspended plans to distribute the AstraZeneca COVID vaccine when the same study showed only 10% efficacy at protecting against mild and moderate COVID-19 cases from the new South African variant.

South Africa’s health minister, Zweli Mkhize, said, “the country would temporarily halt a planned rollout of the vaccine until there was more information on the vaccine’s efficacy” and instead distribute the as of yet unapproved Johnson & Johnson vaccine.

Read more: WHO Approves AstraZeneca Vaccine for Emergency Use (of course it does), But Some Nations Say ‘No Thanks’

The Answer

From our advertisers